Request for Covid-19 Impact Assessment of this Report

Pharmaceuticals

Global Prescription Drugs Market Growth 2022-2028

  • LP 4871484
  • 120 Pages
  • February 2022
  • Pharmaceuticals
Download Sample    Get Discount   
 
As the global economy mends, the 2021 growth of Prescription Drugs will have significant change from previous year. According to our (LP Information) latest study, the global Prescription Drugs market size is USD million in 2022 from USD million in 2021, with a change of % between 2021 and 2022. The global Prescription Drugs market size will reach USD million in 2028, growing at a CAGR of % over the analysis period.

The United States Prescription Drugs market is expected at value of US$ million in 2021 and grow at approximately % CAGR during review period. China constitutes a % market for the global Prescription Drugs market, reaching US$ million by the year 2028. As for the Europe Prescription Drugs landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period. In APAC, the growth rates of other notable markets (Japan and South Korea) are projected to be at % and % respectively for the next 5-year period.

Global main Prescription Drugs players cover Pfizer, Roche, Sanofi, and Johnson & Johnson, etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.

This report presents a comprehensive overview, market shares, and growth opportunities of Prescription Drugs market by product type, application, key manufacturers and key regions and countries.

Segmentation by type: breakdown data from 2017 to 2022, in Section 2.3; and forecast to 2028 in section 12.6

Brand Drugs

Generic Drug

Segmentation by application: breakdown data from 2017 to 2022, in Section 2.4; and forecast to 2028 in section 12.7.

Hospital

Clinic

Other

This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.

Americas

United States

Canada

Mexico

Brazil

APAC

China

Japan

Korea

Southeast Asia

India

Australia

Europe

Germany

France

UK

Italy

Russia

Middle East & Africa

Egypt

South Africa

Israel

Turkey

GCC Countries

The report also presents the market competition landscape and a corresponding detailed analysis of the prominent manufacturers in this market, include

Pfizer

Roche

Sanofi

Johnson & Johnson

Merck & Co. (MSD)

Novartis

AbbVie

Gilead Sciences

GlaxoSmithKline (GSK)

Amgen

AstraZeneca

Bristol-Myers Squibb

Eli Lilly

Teva

Bayer

Novo Nordisk

Allergan

Takeda

Boehringer Ingelheim

Takeda

1 Scope of the Report

1.1 Market Introduction

1.2 Years Considered

1.3 Research Objectives

1.4 Market Research Methodology

1.5 Research Process and Data Source

1.6 Economic Indicators

1.7 Currency Considered

2 Executive Summary

2.1 World Market Overview

2.1.1 Global Prescription Drugs Annual Sales 2017-2028

2.1.2 World Current & Future Analysis for Prescription Drugs by Geographic Region, 2017, 2022 & 2028

2.1.3 World Current & Future Analysis for Prescription Drugs by Country/Region, 2017, 2022 & 2028

2.2 Prescription Drugs Segment by Type

2.2.1 Brand Drugs

2.2.2 Generic Drug

2.3 Prescription Drugs Sales by Type

2.3.1 Global Prescription Drugs Sales Market Share by Type (2017-2022)

2.3.2 Global Prescription Drugs Revenue and Market Share by Type (2017-2022)

2.3.3 Global Prescription Drugs Sale Price by Type (2017-2022)

2.4 Prescription Drugs Segment by Application

2.4.1 Hospital

2.4.2 Clinic

2.4.3 Other

2.5 Prescription Drugs Sales by Application

2.5.1 Global Prescription Drugs Sale Market Share by Application (2017-2022)

2.5.2 Global Prescription Drugs Revenue and Market Share by Application (2017-2022)

2.5.3 Global Prescription Drugs Sale Price by Application (2017-2022)

3 Global Prescription Drugs by Company

3.1 Global Prescription Drugs Breakdown Data by Company

3.1.1 Global Prescription Drugs Annual Sales by Company (2020-2022)

3.1.2 Global Prescription Drugs Sales Market Share by Company (2020-2022)

3.2 Global Prescription Drugs Annual Revenue by Company (2020-2022)

3.2.1 Global Prescription Drugs Revenue by Company (2020-2022)

3.2.2 Global Prescription Drugs Revenue Market Share by Company (2020-2022)

3.3 Global Prescription Drugs Sale Price by Company

3.4 Key Manufacturers Prescription Drugs Producing Area Distribution, Sales Area, Product Type

3.4.1 Key Manufacturers Prescription Drugs Product Location Distribution

3.4.2 Players Prescription Drugs Products Offered

3.5 Market Concentration Rate Analysis

3.5.1 Competition Landscape Analysis

3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)

3.6 New Products and Potential Entrants

3.7 Mergers & Acquisitions, Expansion

4 World Historic Review for Prescription Drugs by Geographic Region

4.1 World Historic Prescription Drugs Market Size by Geographic Region (2017-2022)

4.1.1 Global Prescription Drugs Annual Sales by Geographic Region (2017-2022)

4.1.2 Global Prescription Drugs Annual Revenue by Geographic Region

4.2 World Historic Prescription Drugs Market Size by Country/Region (2017-2022)

4.2.1 Global Prescription Drugs Annual Sales by Country/Region (2017-2022)

4.2.2 Global Prescription Drugs Annual Revenue by Country/Region

4.3 Americas Prescription Drugs Sales Growth

4.4 APAC Prescription Drugs Sales Growth

4.5 Europe Prescription Drugs Sales Growth

4.6 Middle East & Africa Prescription Drugs Sales Growth

5 Americas

5.1 Americas Prescription Drugs Sales by Country

5.1.1 Americas Prescription Drugs Sales by Country (2017-2022)

5.1.2 Americas Prescription Drugs Revenue by Country (2017-2022)

5.2 Americas Prescription Drugs Sales by Type

5.3 Americas Prescription Drugs Sales by Application

5.4 United States

5.5 Canada

5.6 Mexico

5.7 Brazil

6 APAC

6.1 APAC Prescription Drugs Sales by Region

6.1.1 APAC Prescription Drugs Sales by Region (2017-2022)

6.1.2 APAC Prescription Drugs Revenue by Region (2017-2022)

6.2 APAC Prescription Drugs Sales by Type

6.3 APAC Prescription Drugs Sales by Application

6.4 China

6.5 Japan

6.6 South Korea

6.7 Southeast Asia

6.8 India

6.9 Australia

6.10 China Taiwan

7 Europe

7.1 Europe Prescription Drugs by Country

7.1.1 Europe Prescription Drugs Sales by Country (2017-2022)

7.1.2 Europe Prescription Drugs Revenue by Country (2017-2022)

7.2 Europe Prescription Drugs Sales by Type

7.3 Europe Prescription Drugs Sales by Application

7.4 Germany

7.5 France

7.6 UK

7.7 Italy

7.8 Russia

8 Middle East & Africa

8.1 Middle East & Africa Prescription Drugs by Country

8.1.1 Middle East & Africa Prescription Drugs Sales by Country (2017-2022)

8.1.2 Middle East & Africa Prescription Drugs Revenue by Country (2017-2022)

8.2 Middle East & Africa Prescription Drugs Sales by Type

8.3 Middle East & Africa Prescription Drugs Sales by Application

8.4 Egypt

8.5 South Africa

8.6 Israel

8.7 Turkey

8.8 GCC Countries

9 Market Drivers, Challenges and Trends

9.1 Market Drivers & Growth Opportunities

9.2 Market Challenges & Risks

9.3 Industry Trends

10 Manufacturing Cost Structure Analysis

10.1 Raw Material and Suppliers

10.2 Manufacturing Cost Structure Analysis of Prescription Drugs

10.3 Manufacturing Process Analysis of Prescription Drugs

10.4 Industry Chain Structure of Prescription Drugs

11 Marketing, Distributors and Customer

11.1 Sales Channel

11.1.1 Direct Channels

11.1.2 Indirect Channels

11.2 Prescription Drugs Distributors

11.3 Prescription Drugs Customer

12 World Forecast Review for Prescription Drugs by Geographic Region

12.1 Global Prescription Drugs Market Size Forecast by Region

12.1.1 Global Prescription Drugs Forecast by Region (2023-2028)

12.1.2 Global Prescription Drugs Annual Revenue Forecast by Region (2023-2028)

12.2 Americas Forecast by Country

12.3 APAC Forecast by Region

12.4 Europe Forecast by Country

12.5 Middle East & Africa Forecast by Country

12.6 Global Prescription Drugs Forecast by Type

12.7 Global Prescription Drugs Forecast by Application

13 Key Players Analysis

13.1 Pfizer

13.1.1 Pfizer Company Information

13.1.2 Pfizer Prescription Drugs Product Offered

13.1.3 Pfizer Prescription Drugs Sales, Revenue, Price and Gross Margin (2020-2022)

13.1.4 Pfizer Main Business Overview

13.1.5 Pfizer Latest Developments

13.2 Roche

13.2.1 Roche Company Information

13.2.2 Roche Prescription Drugs Product Offered

13.2.3 Roche Prescription Drugs Sales, Revenue, Price and Gross Margin (2020-2022)

13.2.4 Roche Main Business Overview

13.2.5 Roche Latest Developments

13.3 Sanofi

13.3.1 Sanofi Company Information

13.3.2 Sanofi Prescription Drugs Product Offered

13.3.3 Sanofi Prescription Drugs Sales, Revenue, Price and Gross Margin (2020-2022)

13.3.4 Sanofi Main Business Overview

13.3.5 Sanofi Latest Developments

13.4 Johnson & Johnson

13.4.1 Johnson & Johnson Company Information

13.4.2 Johnson & Johnson Prescription Drugs Product Offered

13.4.3 Johnson & Johnson Prescription Drugs Sales, Revenue, Price and Gross Margin (2020-2022)

13.4.4 Johnson & Johnson Main Business Overview

13.4.5 Johnson & Johnson Latest Developments

13.5 Merck & Co. (MSD)

13.5.1 Merck & Co. (MSD) Company Information

13.5.2 Merck & Co. (MSD) Prescription Drugs Product Offered

13.5.3 Merck & Co. (MSD) Prescription Drugs Sales, Revenue, Price and Gross Margin (2020-2022)

13.5.4 Merck & Co. (MSD) Main Business Overview

13.5.5 Merck & Co. (MSD) Latest Developments

13.6 Novartis

13.6.1 Novartis Company Information

13.6.2 Novartis Prescription Drugs Product Offered

13.6.3 Novartis Prescription Drugs Sales, Revenue, Price and Gross Margin (2020-2022)

13.6.4 Novartis Main Business Overview

13.6.5 Novartis Latest Developments

13.7 AbbVie

13.7.1 AbbVie Company Information

13.7.2 AbbVie Prescription Drugs Product Offered

13.7.3 AbbVie Prescription Drugs Sales, Revenue, Price and Gross Margin (2020-2022)

13.7.4 AbbVie Main Business Overview

13.7.5 AbbVie Latest Developments

13.8 Gilead Sciences

13.8.1 Gilead Sciences Company Information

13.8.2 Gilead Sciences Prescription Drugs Product Offered

13.8.3 Gilead Sciences Prescription Drugs Sales, Revenue, Price and Gross Margin (2020-2022)

13.8.4 Gilead Sciences Main Business Overview

13.8.5 Gilead Sciences Latest Developments

13.9 GlaxoSmithKline (GSK)

13.9.1 GlaxoSmithKline (GSK) Company Information

13.9.2 GlaxoSmithKline (GSK) Prescription Drugs Product Offered

13.9.3 GlaxoSmithKline (GSK) Prescription Drugs Sales, Revenue, Price and Gross Margin (2020-2022)

13.9.4 GlaxoSmithKline (GSK) Main Business Overview

13.9.5 GlaxoSmithKline (GSK) Latest Developments

13.10 Amgen

13.10.1 Amgen Company Information

13.10.2 Amgen Prescription Drugs Product Offered

13.10.3 Amgen Prescription Drugs Sales, Revenue, Price and Gross Margin (2020-2022)

13.10.4 Amgen Main Business Overview

13.10.5 Amgen Latest Developments

13.11 AstraZeneca

13.11.1 AstraZeneca Company Information

13.11.2 AstraZeneca Prescription Drugs Product Offered

13.11.3 AstraZeneca Prescription Drugs Sales, Revenue, Price and Gross Margin (2020-2022)

13.11.4 AstraZeneca Main Business Overview

13.11.5 AstraZeneca Latest Developments

13.12 Bristol-Myers Squibb

13.12.1 Bristol-Myers Squibb Company Information

13.12.2 Bristol-Myers Squibb Prescription Drugs Product Offered

13.12.3 Bristol-Myers Squibb Prescription Drugs Sales, Revenue, Price and Gross Margin (2020-2022)

13.12.4 Bristol-Myers Squibb Main Business Overview

13.12.5 Bristol-Myers Squibb Latest Developments

13.13 Eli Lilly

13.13.1 Eli Lilly Company Information

13.13.2 Eli Lilly Prescription Drugs Product Offered

13.13.3 Eli Lilly Prescription Drugs Sales, Revenue, Price and Gross Margin (2020-2022)

13.13.4 Eli Lilly Main Business Overview

13.13.5 Eli Lilly Latest Developments

13.14 Teva

13.14.1 Teva Company Information

13.14.2 Teva Prescription Drugs Product Offered

13.14.3 Teva Prescription Drugs Sales, Revenue, Price and Gross Margin (2020-2022)

13.14.4 Teva Main Business Overview

13.14.5 Teva Latest Developments

13.15 Bayer

13.15.1 Bayer Company Information

13.15.2 Bayer Prescription Drugs Product Offered

13.15.3 Bayer Prescription Drugs Sales, Revenue, Price and Gross Margin (2020-2022)

13.15.4 Bayer Main Business Overview

13.15.5 Bayer Latest Developments

13.16 Novo Nordisk

13.16.1 Novo Nordisk Company Information

13.16.2 Novo Nordisk Prescription Drugs Product Offered

13.16.3 Novo Nordisk Prescription Drugs Sales, Revenue, Price and Gross Margin (2020-2022)

13.16.4 Novo Nordisk Main Business Overview

13.16.5 Novo Nordisk Latest Developments

13.17 Allergan

13.17.1 Allergan Company Information

13.17.2 Allergan Prescription Drugs Product Offered

13.17.3 Allergan Prescription Drugs Sales, Revenue, Price and Gross Margin (2020-2022)

13.17.4 Allergan Main Business Overview

13.17.5 Allergan Latest Developments

13.18 Takeda

13.18.1 Takeda Company Information

13.18.2 Takeda Prescription Drugs Product Offered

13.18.3 Takeda Prescription Drugs Sales, Revenue, Price and Gross Margin (2020-2022)

13.18.4 Takeda Main Business Overview

13.18.5 Takeda Latest Developments

13.19 Boehringer Ingelheim

13.19.1 Boehringer Ingelheim Company Information

13.19.2 Boehringer Ingelheim Prescription Drugs Product Offered

13.19.3 Boehringer Ingelheim Prescription Drugs Sales, Revenue, Price and Gross Margin (2020-2022)

13.19.4 Boehringer Ingelheim Main Business Overview

13.19.5 Boehringer Ingelheim Latest Developments

13.20 Takeda

13.20.1 Takeda Company Information

13.20.2 Takeda Prescription Drugs Product Offered

13.20.3 Takeda Prescription Drugs Sales, Revenue, Price and Gross Margin (2020-2022)

13.20.4 Takeda Main Business Overview

13.20.5 Takeda Latest Developments

14 Research Findings and Conclusion

List of Tables

Table 1. Prescription Drugs Annual Sales CAGR by Geographic Region (2017, 2022 & 2028) & ($ millions)

Table 2. Prescription Drugs Annual Sales CAGR by Country/Region (2017, 2022 & 2028) & ($ millions)

Table 3. Major Players of Brand Drugs

Table 4. Major Players of Generic Drug

Table 5. Global Prescription Drugs Sales by Type (2017-2022) & (K Units)

Table 6. Global Prescription Drugs Sales Market Share by Type (2017-2022)

Table 7. Global Prescription Drugs Revenue by Type (2017-2022) & ($ million)

Table 8. Global Prescription Drugs Revenue Market Share by Type (2017-2022)

Table 9. Global Prescription Drugs Sale Price by Type (2017-2022) & (USD/Unit)

Table 10. Global Prescription Drugs Sales by Application (2017-2022) & (K Units)

Table 11. Global Prescription Drugs Sales Market Share by Application (2017-2022)

Table 12. Global Prescription Drugs Revenue by Application (2017-2022)

Table 13. Global Prescription Drugs Revenue Market Share by Application (2017-2022)

Table 14. Global Prescription Drugs Sale Price by Application (2017-2022) & (USD/Unit)

Table 15. Global Prescription Drugs Sales by Company (2020-2022) & (K Units)

Table 16. Global Prescription Drugs Sales Market Share by Company (2020-2022)

Table 17. Global Prescription Drugs Revenue by Company (2020-2022) ($ Millions)

Table 18. Global Prescription Drugs Revenue Market Share by Company (2020-2022)

Table 19. Global Prescription Drugs Sale Price by Company (2020-2022) & (USD/Unit)

Table 20. Key Manufacturers Prescription Drugs Producing Area Distribution and Sales Area

Table 21. Players Prescription Drugs Products Offered

Table 22. Prescription Drugs Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)

Table 23. New Products and Potential Entrants

Table 24. Mergers & Acquisitions, Expansion

Table 25. Global Prescription Drugs Sales by Geographic Region (2017-2022) & (K Units)

Table 26. Global Prescription Drugs Sales Market Share Geographic Region (2017-2022)

Table 27. Global Prescription Drugs Revenue by Geographic Region (2017-2022) & ($ millions)

Table 28. Global Prescription Drugs Revenue Market Share by Geographic Region (2017-2022)

Table 29. Global Prescription Drugs Sales by Country/Region (2017-2022) & (K Units)

Table 30. Global Prescription Drugs Sales Market Share by Country/Region (2017-2022)

Table 31. Global Prescription Drugs Revenue by Country/Region (2017-2022) & ($ millions)

Table 32. Global Prescription Drugs Revenue Market Share by Country/Region (2017-2022)

Table 33. Americas Prescription Drugs Sales by Country (2017-2022) & (K Units)

Table 34. Americas Prescription Drugs Sales Market Share by Country (2017-2022)

Table 35. Americas Prescription Drugs Revenue by Country (2017-2022) & ($ Millions)

Table 36. Americas Prescription Drugs Revenue Market Share by Country (2017-2022)

Table 37. Americas Prescription Drugs Sales by Type (2017-2022) & (K Units)

Table 38. Americas Prescription Drugs Sales Market Share by Type (2017-2022)

Table 39. Americas Prescription Drugs Sales by Application (2017-2022) & (K Units)

Table 40. Americas Prescription Drugs Sales Market Share by Application (2017-2022)

Table 41. APAC Prescription Drugs Sales by Region (2017-2022) & (K Units)

Table 42. APAC Prescription Drugs Sales Market Share by Region (2017-2022)

Table 43. APAC Prescription Drugs Revenue by Region (2017-2022) & ($ Millions)

Table 44. APAC Prescription Drugs Revenue Market Share by Region (2017-2022)

Table 45. APAC Prescription Drugs Sales by Type (2017-2022) & (K Units)

Table 46. APAC Prescription Drugs Sales Market Share by Type (2017-2022)

Table 47. APAC Prescription Drugs Sales by Application (2017-2022) & (K Units)

Table 48. APAC Prescription Drugs Sales Market Share by Application (2017-2022)

Table 49. Europe Prescription Drugs Sales by Country (2017-2022) & (K Units)

Table 50. Europe Prescription Drugs Sales Market Share by Country (2017-2022)

Table 51. Europe Prescription Drugs Revenue by Country (2017-2022) & ($ Millions)

Table 52. Europe Prescription Drugs Revenue Market Share by Country (2017-2022)

Table 53. Europe Prescription Drugs Sales by Type (2017-2022) & (K Units)

Table 54. Europe Prescription Drugs Sales Market Share by Type (2017-2022)

Table 55. Europe Prescription Drugs Sales by Application (2017-2022) & (K Units)

Table 56. Europe Prescription Drugs Sales Market Share by Application (2017-2022)

Table 57. Middle East & Africa Prescription Drugs Sales by Country (2017-2022) & (K Units)

Table 58. Middle East & Africa Prescription Drugs Sales Market Share by Country (2017-2022)

Table 59. Middle East & Africa Prescription Drugs Revenue by Country (2017-2022) & ($ Millions)

Table 60. Middle East & Africa Prescription Drugs Revenue Market Share by Country (2017-2022)

Table 61. Middle East & Africa Prescription Drugs Sales by Type (2017-2022) & (K Units)

Table 62. Middle East & Africa Prescription Drugs Sales Market Share by Type (2017-2022)

Table 63. Middle East & Africa Prescription Drugs Sales by Application (2017-2022) & (K Units)

Table 64. Middle East & Africa Prescription Drugs Sales Market Share by Application (2017-2022)

Table 65. Key Market Drivers & Growth Opportunities of Prescription Drugs

Table 66. Key Market Challenges & Risks of Prescription Drugs

Table 67. Key Industry Trends of Prescription Drugs

Table 68. Prescription Drugs Raw Material

Table 69. Key Suppliers of Raw Materials

Table 70. Prescription Drugs Distributors List

Table 71. Prescription Drugs Customer List

Table 72. Global Prescription Drugs Sales Forecast by Region (2023-2028) & (K Units)

Table 73. Global Prescription Drugs Sales Market Forecast by Region

Table 74. Global Prescription Drugs Revenue Forecast by Region (2023-2028) & ($ millions)

Table 75. Global Prescription Drugs Revenue Market Share Forecast by Region (2023-2028)

Table 76. Americas Prescription Drugs Sales Forecast by Country (2023-2028) & (K Units)

Table 77. Americas Prescription Drugs Revenue Forecast by Country (2023-2028) & ($ millions)

Table 78. APAC Prescription Drugs Sales Forecast by Region (2023-2028) & (K Units)

Table 79. APAC Prescription Drugs Revenue Forecast by Region (2023-2028) & ($ millions)

Table 80. Europe Prescription Drugs Sales Forecast by Country (2023-2028) & (K Units)

Table 81. Europe Prescription Drugs Revenue Forecast by Country (2023-2028) & ($ millions)

Table 82. Middle East & Africa Prescription Drugs Sales Forecast by Country (2023-2028) & (K Units)

Table 83. Middle East & Africa Prescription Drugs Revenue Forecast by Country (2023-2028) & ($ millions)

Table 84. Global Prescription Drugs Sales Forecast by Type (2023-2028) & (K Units)

Table 85. Global Prescription Drugs Sales Market Share Forecast by Type (2023-2028)

Table 86. Global Prescription Drugs Revenue Forecast by Type (2023-2028) & ($ Millions)

Table 87. Global Prescription Drugs Revenue Market Share Forecast by Type (2023-2028)

Table 88. Global Prescription Drugs Sales Forecast by Application (2023-2028) & (K Units)

Table 89. Global Prescription Drugs Sales Market Share Forecast by Application (2023-2028)

Table 90. Global Prescription Drugs Revenue Forecast by Application (2023-2028) & ($ Millions)

Table 91. Global Prescription Drugs Revenue Market Share Forecast by Application (2023-2028)

Table 92. Pfizer Basic Information, Prescription Drugs Manufacturing Base, Sales Area and Its Competitors

Table 93. Pfizer Prescription Drugs Product Offered

Table 94. Pfizer Prescription Drugs Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)

Table 95. Pfizer Main Business

Table 96. Pfizer Latest Developments

Table 97. Roche Basic Information, Prescription Drugs Manufacturing Base, Sales Area and Its Competitors

Table 98. Roche Prescription Drugs Product Offered

Table 99. Roche Prescription Drugs Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)

Table 100. Roche Main Business

Table 101. Roche Latest Developments

Table 102. Sanofi Basic Information, Prescription Drugs Manufacturing Base, Sales Area and Its Competitors

Table 103. Sanofi Prescription Drugs Product Offered

Table 104. Sanofi Prescription Drugs Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)

Table 105. Sanofi Main Business

Table 106. Sanofi Latest Developments

Table 107. Johnson & Johnson Basic Information, Prescription Drugs Manufacturing Base, Sales Area and Its Competitors

Table 108. Johnson & Johnson Prescription Drugs Product Offered

Table 109. Johnson & Johnson Prescription Drugs Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)

Table 110. Johnson & Johnson Main Business

Table 111. Johnson & Johnson Latest Developments

Table 112. Merck & Co. (MSD) Basic Information, Prescription Drugs Manufacturing Base, Sales Area and Its Competitors

Table 113. Merck & Co. (MSD) Prescription Drugs Product Offered

Table 114. Merck & Co. (MSD) Prescription Drugs Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)

Table 115. Merck & Co. (MSD) Main Business

Table 116. Merck & Co. (MSD) Latest Developments

Table 117. Novartis Basic Information, Prescription Drugs Manufacturing Base, Sales Area and Its Competitors

Table 118. Novartis Prescription Drugs Product Offered

Table 119. Novartis Prescription Drugs Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)

Table 120. Novartis Main Business

Table 121. Novartis Latest Developments

Table 122. AbbVie Basic Information, Prescription Drugs Manufacturing Base, Sales Area and Its Competitors

Table 123. AbbVie Prescription Drugs Product Offered

Table 124. AbbVie Prescription Drugs Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)

Table 125. AbbVie Main Business

Table 126. AbbVie Latest Developments

Table 127. Gilead Sciences Basic Information, Prescription Drugs Manufacturing Base, Sales Area and Its Competitors

Table 128. Gilead Sciences Prescription Drugs Product Offered

Table 129. Gilead Sciences Prescription Drugs Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)

Table 130. Gilead Sciences Main Business

Table 131. Gilead Sciences Latest Developments

Table 132. GlaxoSmithKline (GSK) Basic Information, Prescription Drugs Manufacturing Base, Sales Area and Its Competitors

Table 133. GlaxoSmithKline (GSK) Prescription Drugs Product Offered

Table 134. GlaxoSmithKline (GSK) Prescription Drugs Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)

Table 135. GlaxoSmithKline (GSK) Main Business

Table 136. GlaxoSmithKline (GSK) Latest Developments

Table 137. Amgen Basic Information, Prescription Drugs Manufacturing Base, Sales Area and Its Competitors

Table 138. Amgen Prescription Drugs Product Offered

Table 139. Amgen Prescription Drugs Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)

Table 140. Amgen Main Business

Table 141. Amgen Latest Developments

Table 142. AstraZeneca Basic Information, Prescription Drugs Manufacturing Base, Sales Area and Its Competitors

Table 143. AstraZeneca Prescription Drugs Product Offered

Table 144. AstraZeneca Prescription Drugs Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)

Table 145. AstraZeneca Main Business

Table 146. AstraZeneca Latest Developments

Table 147. Bristol-Myers Squibb Basic Information, Prescription Drugs Manufacturing Base, Sales Area and Its Competitors

Table 148. Bristol-Myers Squibb Prescription Drugs Product Offered

Table 149. Bristol-Myers Squibb Prescription Drugs Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)

Table 150. Bristol-Myers Squibb Main Business

Table 151. Bristol-Myers Squibb Latest Developments

Table 152. Eli Lilly Basic Information, Prescription Drugs Manufacturing Base, Sales Area and Its Competitors

Table 153. Eli Lilly Prescription Drugs Product Offered

Table 154. Eli Lilly Prescription Drugs Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)

Table 155. Eli Lilly Main Business

Table 156. Eli Lilly Latest Developments

Table 157. Teva Basic Information, Prescription Drugs Manufacturing Base, Sales Area and Its Competitors

Table 158. Teva Prescription Drugs Product Offered

Table 159. Teva Prescription Drugs Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)

Table 160. Teva Main Business

Table 161. Teva Latest Developments

Table 162. Bayer Basic Information, Prescription Drugs Manufacturing Base, Sales Area and Its Competitors

Table 163. Bayer Prescription Drugs Product Offered

Table 164. Bayer Prescription Drugs Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)

Table 165. Bayer Main Business

Table 166. Bayer Latest Developments

Table 167. Novo Nordisk Basic Information, Prescription Drugs Manufacturing Base, Sales Area and Its Competitors

Table 168. Novo Nordisk Prescription Drugs Product Offered

Table 169. Novo Nordisk Prescription Drugs Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)

Table 170. Novo Nordisk Main Business

Table 171. Novo Nordisk Latest Developments

Table 172. Allergan Basic Information, Prescription Drugs Manufacturing Base, Sales Area and Its Competitors

Table 173. Allergan Prescription Drugs Product Offered

Table 174. Allergan Prescription Drugs Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)

Table 175. Allergan Main Business

Table 176. Allergan Latest Developments

Table 177. Takeda Basic Information, Prescription Drugs Manufacturing Base, Sales Area and Its Competitors

Table 178. Takeda Prescription Drugs Product Offered

Table 179. Takeda Prescription Drugs Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)

Table 180. Takeda Main Business

Table 181. Takeda Latest Developments

Table 182. Boehringer Ingelheim Basic Information, Prescription Drugs Manufacturing Base, Sales Area and Its Competitors

Table 183. Boehringer Ingelheim Prescription Drugs Product Offered

Table 184. Boehringer Ingelheim Prescription Drugs Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)

Table 185. Boehringer Ingelheim Main Business

Table 186. Boehringer Ingelheim Latest Developments

Table 187. Takeda Basic Information, Prescription Drugs Manufacturing Base, Sales Area and Its Competitors

Table 188. Takeda Prescription Drugs Product Offered

Table 189. Takeda Prescription Drugs Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)

Table 190. Takeda Main Business

Table 191. Takeda Latest Developments

List of Figures

Figure 1. Picture of Prescription Drugs

Figure 2. Prescription Drugs Report Years Considered

Figure 3. Research Objectives

Figure 4. Research Methodology

Figure 5. Research Process and Data Source

Figure 6. Global Prescription Drugs Sales Growth Rate 2017-2028 (K Units)

Figure 7. Global Prescription Drugs Revenue Growth Rate 2017-2028 ($ Millions)

Figure 8. Prescription Drugs Sales by Region (2021 & 2028) & ($ millions)

Figure 9. Product Picture of Brand Drugs

Figure 10. Product Picture of Generic Drug

Figure 11. Global Prescription Drugs Sales Market Share by Type in 2021

Figure 12. Global Prescription Drugs Revenue Market Share by Type (2017-2022)

Figure 13. Prescription Drugs Consumed in Hospital

Figure 14. Global Prescription Drugs Market: Hospital (2017-2022) & (K Units)

Figure 15. Prescription Drugs Consumed in Clinic

Figure 16. Global Prescription Drugs Market: Clinic (2017-2022) & (K Units)

Figure 17. Prescription Drugs Consumed in Other

Figure 18. Global Prescription Drugs Market: Other (2017-2022) & (K Units)

Figure 19. Global Prescription Drugs Sales Market Share by Application (2017-2022)

Figure 20. Global Prescription Drugs Revenue Market Share by Application in 2021

Figure 21. Prescription Drugs Revenue Market by Company in 2021 ($ Million)

Figure 22. Global Prescription Drugs Revenue Market Share by Company in 2021

Figure 23. Global Prescription Drugs Sales Market Share by Geographic Region (2017-2022)

Figure 24. Global Prescription Drugs Revenue Market Share by Geographic Region in 2021

Figure 25. Global Prescription Drugs Sales Market Share by Region (2017-2022)

Figure 26. Global Prescription Drugs Revenue Market Share by Country/Region in 2021

Figure 27. Americas Prescription Drugs Sales 2017-2022 (K Units)

Figure 28. Americas Prescription Drugs Revenue 2017-2022 ($ Millions)

Figure 29. APAC Prescription Drugs Sales 2017-2022 (K Units)

Figure 30. APAC Prescription Drugs Revenue 2017-2022 ($ Millions)

Figure 31. Europe Prescription Drugs Sales 2017-2022 (K Units)

Figure 32. Europe Prescription Drugs Revenue 2017-2022 ($ Millions)

Figure 33. Middle East & Africa Prescription Drugs Sales 2017-2022 (K Units)

Figure 34. Middle East & Africa Prescription Drugs Revenue 2017-2022 ($ Millions)

Figure 35. Americas Prescription Drugs Sales Market Share by Country in 2021

Figure 36. Americas Prescription Drugs Revenue Market Share by Country in 2021

Figure 37. United States Prescription Drugs Revenue Growth 2017-2022 ($ Millions)

Figure 38. Canada Prescription Drugs Revenue Growth 2017-2022 ($ Millions)

Figure 39. Mexico Prescription Drugs Revenue Growth 2017-2022 ($ Millions)

Figure 40. Brazil Prescription Drugs Revenue Growth 2017-2022 ($ Millions)

Figure 41. APAC Prescription Drugs Sales Market Share by Region in 2021

Figure 42. APAC Prescription Drugs Revenue Market Share by Regions in 2021

Figure 43. China Prescription Drugs Revenue Growth 2017-2022 ($ Millions)

Figure 44. Japan Prescription Drugs Revenue Growth 2017-2022 ($ Millions)

Figure 45. South Korea Prescription Drugs Revenue Growth 2017-2022 ($ Millions)

Figure 46. Southeast Asia Prescription Drugs Revenue Growth 2017-2022 ($ Millions)

Figure 47. India Prescription Drugs Revenue Growth 2017-2022 ($ Millions)

Figure 48. Australia Prescription Drugs Revenue Growth 2017-2022 ($ Millions)

Figure 49. Europe Prescription Drugs Sales Market Share by Country in 2021

Figure 50. Europe Prescription Drugs Revenue Market Share by Country in 2021

Figure 51. Germany Prescription Drugs Revenue Growth 2017-2022 ($ Millions)

Figure 52. France Prescription Drugs Revenue Growth 2017-2022 ($ Millions)

Figure 53. UK Prescription Drugs Revenue Growth 2017-2022 ($ Millions)

Figure 54. Italy Prescription Drugs Revenue Growth 2017-2022 ($ Millions)

Figure 55. Russia Prescription Drugs Revenue Growth 2017-2022 ($ Millions)

Figure 56. Middle East & Africa Prescription Drugs Sales Market Share by Country in 2021

Figure 57. Middle East & Africa Prescription Drugs Revenue Market Share by Country in 2021

Figure 58. Egypt Prescription Drugs Revenue Growth 2017-2022 ($ Millions)

Figure 59. South Africa Prescription Drugs Revenue Growth 2017-2022 ($ Millions)

Figure 60. Israel Prescription Drugs Revenue Growth 2017-2022 ($ Millions)

Figure 61. Turkey Prescription Drugs Revenue Growth 2017-2022 ($ Millions)

Figure 62. GCC Country Prescription Drugs Revenue Growth 2017-2022 ($ Millions)

Figure 63. Manufacturing Cost Structure Analysis of Prescription Drugs in 2021

Figure 64. Manufacturing Process Analysis of Prescription Drugs

Figure 65. Industry Chain Structure of Prescription Drugs

Figure 66. Channels of Distribution

Figure 67. Distributors Profiles

 
Purchase Options

* Taxes/Fees, If applicable will be
added during checkout. All prices in USD.

Need More Information

Contact Us

+ 1-888-961-4454

Drop Us an email at

help@bigmarketresearch.com

Similar Reports

United States Pneumococcal & Meningococcal Vaccines Market by Company Profile, Deals Type, Brand Analysis, Share, Key Trends & Opportunities to 2025

The United States pneumococcal & meningococcal vaccines market is set to surpass US$ 7.5 Million by the year end of 2025. “United States Pneumococcal & Meningococcal Vaccines Market by Company Profile, Deals Type, Brand Analysis, Share, Key Trends & Opportunities to 2025” presents an in–depth assessment of the United States pneumococcal & meningococcal vaccines market dynamics, opportunitie...

  • Publish Date: June 24, 2019
  • $1050
Global Human Immunodeficiency Virus (HIV) Drugs Market 2019 – 2025: Top 22 Drugs Analysis, Key Trends, Players and Forecasts

The global human immunodeficiency virus (HIV) drugs market size is expected to surpass US$ 30 billion by 2025. “Global Human Immunodeficiency Virus (HIV) Drugs Market 2019 – 2025: Top 22 Drugs Analysis, Key Trends, Players and Forecasts” presents an in-depth assessment of the global human immunodeficiency virus (HIV) drugs market dynamics, opportunities, future roadmap, competitive landscap...

  • Publish Date: February 18, 2019
  • $1290
Global Blockbuster Drugs Market 2015 - 2025: Top 50 Drugs Analysis, Deal Trends, Players and Forecasts

The global 50 blockbuster drugs market size is estimated to reach a value of US$ 292 billion by 2025. ‘’Global Blockbuster Drugs Market 2015 - 2025: Top 50 Drugs Analysis, Deal Trends, Players and Forecasts” presents an in-depth assessment of the global blockbuster drugs market dynamics, opportunities, future roadmap, competitive landscape and discusses major trends. The report offers the m...

  • Publish Date: December 11, 2018
  • $1390